Equibles does not estimate personal net worth.
Get an email with a short summary when Biomarin Pharmaceutical Inc publishes a filing, an earnings call transcript or a press release.
Get BMRN alertsThe proxy statement of Biomarin Pharmaceutical Inc reports total compensation of $7,174,583 for Gregory Friberg in fiscal 2025, including a base salary of $705,654. Disclosed compensation is on record for 2 fiscal years. Gregory Friberg has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Biomarin Pharmaceutical Inc on September 9, 2026. Biomarin Pharmaceutical Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Biomarin Pharmaceutical Inc includes Alexander Hardy (CEO and Board Member), Richard A. Meier (Chairman), Brian Mueller (CFO) and 7 others.
“So it's pretty typical in single-dose studies to test one dose higher than you're going to go in your multi-dose study. And that has to do with the fact that, you know, it's a 100-hour half-life molecule.”
“The second quarter was a productive period for our pipeline with meaningful progress across our portfolio turning to slide 16 you can see that we have had a lot of positive news over the last few months i am particularly pleased to highlight our very recent submission of the supplemental nda for voxogo for the…”
“Now moving to slide 16, and to provide a little more color, hypochondroplasia is a serious condition with a potentially broad impact on the health and daily life of those affected.”
Proxy statement
Start not stated–present
Last confirmed April 21, 2026
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Chief Research & Development Officer — | $705,654 | $7,174,583 |
| 2024 | Biomarin Pharmaceutical Inc (BMRN) | Executive Vice President, Chief Research & Development Officer — — | $161,538 | $7,221,559 |
